Arkansas Legal Resource Navigator

22 U.S.C. § 7653 — Annual reports on prevention of mother-

Federal law — U.S. Code and appendices · legal_authorities

22 U.S.C. § 7653 — Annual reports on prevention of mother-

Page 1992 TITLE 22—FOREIGN RELATIONS AND INTERCOURSE § 7653 as a nonvoting member. The Panel shall con- sist of not more than 15 members (excluding the Global AIDS Coordinator), to be appointed by the Global AIDS Coordinator not later than 1 year after July 30, 2008, including— (A) 2 members from the Department of Health and Human Services with expertise relating to the prevention of mother-to-child transmission activities; (B) 2 members from the United States Agency for International Development with expertise relating to the prevention of moth- er-to-child transmission activities; (C) 2 representatives from among health ministers of national governments of foreign countries in which programs under this chapter are administered; (D) 3 members representing organizations implementing prevention of mother-to-child transmission activities under this chapter; (E) 2 health care researchers with exper- tise relating to global HIV/AIDS activities; and (F) representatives from among patient advocate groups, health care professionals, persons living with HIV/AIDS, and non-gov- ernmental organizations with expertise re- lating to the prevention of mother-to-child transmission activities, giving priority to individuals in foreign countries in which programs under this chapter are adminis- tered. (3) Duties of Panel The Panel shall— (A) assess the effectiveness of current ac- tivities in reaching the target described in subsection (b)(1); (B) review scientific evidence related to the provision of mother-to-child trans- mission prevention services, including pro- grammatic data and data from clinical trials; (C) review and assess ways in which the Of- fice of the United States Global AIDS Coor- dinator collaborates with international and multilate

Source: Supplied 2024 U.S. Code historical extraction · 22 U.S.C. § 7653

Stored review status: historical_2024_not_currentness_verified. A text match is a research starting point; applicability is not established.

Original supplied file — preserved unchanged

Download original Markdown file

File SHA-256: 4eaf977c0f52d9da426fdae10543a5245c918820615f9e3431f0463bb8573291. The original may include catalog metadata, neighboring provisions, or embedded records outside this collection's scope. Search shows only the selected federal record. Historical editions and unverified snapshots are not a statement of current law.

Authority boundary: historical or unconfirmed source not current law verified.

Open the recorded source website ↗

Record provenance

Stable record: federal_law:legal_authorities:usc2024-e570bcaa82365693a697a6c5
Source file: Laws/federal/codes/united-states-code-2024/title-22/section-7653-annual-reports-on-prevention-of-mother--375deee5b3.md
Pages: Not recorded – Not recorded
Passage SHA-256: 9e6553cc2e0e2197be53563bc100e65ddb51c0b6e322492a0454e19ece26d0d1

Source location: USCODE-2024-title22-chap83-subchapIII-partB-sec7653.pdf

Stored source content

Page 1992 TITLE 22—FOREIGN RELATIONS AND INTERCOURSE § 7653 as a nonvoting member. The Panel shall con- sist of not more than 15 members (excluding the Global AIDS Coordinator), to be appointed by the Global AIDS Coordinator not later than 1 year after July 30, 2008, including— (A) 2 members from the Department of Health and Human Services with expertise relating to the prevention of mother-to-child transmission activities; (B) 2 members from the United States Agency for International Development with expertise relating to the prevention of moth- er-to-child transmission activities; (C) 2 representatives from among health ministers of national governments of foreign countries in which programs under this chapter are administered; (D) 3 members representing organizations implementing prevention of mother-to-child transmission activities under this chapter; (E) 2 health care researchers with exper- tise relating to global HIV/AIDS activities; and (F) representatives from among patient advocate groups, health care professionals, persons living with HIV/AIDS, and non-gov- ernmental organizations with expertise re- lating to the prevention of mother-to-child transmission activities, giving priority to individuals in foreign countries in which programs under this chapter are adminis- tered. (3) Duties of Panel The Panel shall— (A) assess the effectiveness of current ac- tivities in reaching the target described in subsection (b)(1); (B) review scientific evidence related to the provision of mother-to-child trans- mission prevention services, including pro- grammatic data and data from clinical trials; (C) review and assess ways in which the Of- fice of the United States Global AIDS Coor- dinator collaborates with international and multilateral entities on efforts to prevent mother-to-child transmission of HIV in af- fected countries; (D) identify barriers and challenges to in- creasing access to mother-to-child trans- mission prevention services and evaluate po- tential mechanisms to alleviate those bar- riers and challenges; (E) identify the extent to which stigma has hindered pregnant women from obtaining HIV counseling and testing or returning for results, and provide recommendations to ad- dress such stigma and its effects; (F) identify opportunities to improve link- ages between mother-to-child transmission prevention services and care and treatment programs; and (G) recommend specific activities to facili- tate reaching the target described in sub- section (b)(1). (4) Report (A) In general Not later than 1 year after the date on which the Panel is first convened, the Panel shall submit a report containing a detailed statement of the recommendations, findings, and conclusions of the Panel to the appro- priate congressional committees. (B) Availability The report submitted under subparagraph (A) shall be made available to the public. (C) Consideration by Coordinator The Coordinator shall— (i) consider any recommendations con- tained in the report submitted under sub- paragraph (A); and (ii) include in the annual report required under section 2151b–2(f) of this title a de- scription of the activities conducted in re- sponse to the recommendations made by the Panel and an explanation of any rec- ommendations not implemented at the time of the report. (5) Authorization of appropriations There are authorized to be appropriated to the Panel such sums as may be necessary for each of the fiscal years 2009 through 2011 to carry out this section. (6) Termination The Panel shall terminate on the date that is 60 days after the date on which the Panel submits the report to the appropriate congres- sional committees under paragraph (4). (Pub. L. 108–25, title III, § 312, May 27, 2003, 117 Stat. 741; Pub. L. 110–293, title III, §§ 307, 309, July 30, 2008, 122 Stat. 2963, 2964.) Editorial Notes REFERENCES IN TEXT This chapter, referred to in subsecs. (b)(2), (6) and (c)(1), (2), was in the original ‘‘this Act’’, meaning Pub. L. 108–25, May 27, 2003, 117 Stat. 711, which is classified principally to this chapter. For complete classification of this Act to the Code, see Short Title note set out under section 7601 of this title and Tables. AMENDMENTS 2008—Subsec. (b)(1) to (6). Pub. L. 110–293, § 307, added pars. (1) to (6) and struck out former pars. (1) to (3) which read as follows: ‘‘(1) provide for meeting or exceeding the goal to re- duce the rate of mother-to-child transmission of HIV by 20 percent by 2005 and by 50 percent by 2010; ‘‘(2) include programs to make available testing and treatment to HIV-positive women and their family members, including drug treatment and therapies to prevent mother-to-child transmission; and ‘‘(3) expand programs designed to care for children or- phaned by AIDS.’’ Subsec. (c). Pub. L. 110–293, § 309, added subsec. (c). § 7653. Annual reports on prevention of mother- to-child transmission of the HIV infection (a) In general Not later than 1 year after May 27, 2003, and annually thereafter for a period of 10 years, the President shall submit to appropriate congres- sional committees a report on the activities of relevant executive branch agencies during the reporting period to assist in the prevention of mother-to-child transmission of the HIV infec- tion. Page 1993 TITLE 22—FOREIGN RELATIONS AND INTERCOURSE § 7655 (b) Report elements Each report shall include— (1) a statement of whether or not all rel- evant executive branch agencies have met the goal described in section 7652(b)(1) of this title; and (2) a description of efforts made by the rel- evant executive branch agencies to expand those activities, including— (A) information on the number of sites supported for the prevention of mother-to- child transmission of the HIV infection; (B) the specific activities supported; (C) the number of women tested and coun- seled; and (D) the number of women receiving pre- ventative drug therapies. (c) Reporting period defined In this section, the term ‘‘reporting period’’ means, in the case of the initial report, the pe- riod since May 27, 2003, and, in the case of any subsequent report, the period since the date of submission of the most recent report. (Pub. L. 108–25, title III, § 313, May 27, 2003, 117 Stat. 741; Pub. L. 110–293, title III, § 308, July 30, 2008, 122 Stat. 2964.) Editorial Notes AMENDMENTS 2008—Subsec. (a). Pub. L. 110–293 substituted ‘‘10 years’’ for ‘‘5 years’’. Executive Documents DELEGATION OF FUNCTIONS For delegation of functions of President under this section, see Ex. Ord. No. 12163, Sept. 29, 1979, 44 F.R. 56673, as amended, set out as a note under section 2381 of this title, and Memorandum of President of Feb. 23, 2004, 69 F.R. 9509, set out as a note under section 7611 of this title. § 7654. Pilot program of assistance for children and families affected by HIV/AIDS (a) In general The President, acting through the United States Agency for International Development, should establish a program of assistance that would demonstrate the feasibility of the provi- sion of care and treatment to orphans and other children and young people affected by HIV/AIDS in foreign countries. (b) Program requirements The program should— (1) build upon and be integrated into pro- grams administered as of May 27, 2003, by the relevant executive branch agencies for chil- dren affected by HIV/AIDS; (2) work in conjunction with indigenous community-based programs and activities, particularly those that offer proven services for children; (3) reduce the stigma of HIV/AIDS to encour- age vulnerable children infected with HIV or living with AIDS and their family members and caregivers to avail themselves of vol- untary counseling and testing, and related programs, including treatments; (4) ensure the importance of inheritance rights of women, particularly women in Afri- can countries, due to the exponential growth in the number of young widows, orphaned girls, and grandmothers becoming heads of households as a result of the HIV/AIDS pan- demic; (5) provide, in conjunction with other rel- evant executive branch agencies, the range of services for the care and treatment, including the provision of antiretrovirals and other nec- essary pharmaceuticals, of children, parents, and caregivers infected with HIV or living with AIDS; (6) provide nutritional support and food se- curity, and the improvement of overall family health; (7) work with parents, caregivers, and com- munity-based organizations to provide chil- dren with educational opportunities; and (8) provide appropriate counseling and legal assistance for the appointment of guardians and the handling of other issues relating to the protection of children. (c) Report Not later than 18 months after May 27, 2003, the President should submit a report on the im- plementation of this section to the appropriate congressional committees. Such report should include a description of activities undertaken to carry out subsection (b)(4). (d) Authorization of appropriations (1) In general In addition to amounts otherwise available for such purpose, there are authorized to be appropriated to the President, from amounts authorized to be appropriated under section 7671 of this title, such sums as may be nec- essary for each of the fiscal years 2004 through 2008 to carry out the program. A significant percentage of the amount appropriated pursu- ant to the authorization of appropriations under the preceding sentence for a fiscal year should be made available to carry out sub- section (b)(4). (2) Availability of funds Amounts appropriated pursuant to para- graph (1) are authorized to remain available until expended. (Pub. L. 108–25, title III, § 314, May 27, 2003, 117 Stat. 742.) Executive Documents DELEGATION OF FUNCTIONS For delegation of functions of President under this section, see Ex. Ord. No. 12163, Sept. 29, 1979, 44 F.R. 56673, as amended, set out as a note under section 2381 of this title. § 7655. Pilot program on family survival partner- ships (a) Purpose The purpose of this section is to authorize the President to establish a program, through a pub- lic-private partnership, for the provision of med- ical care and support services to HIV positive parents and their children identified through ex-

Cross-references

Connections may be documented source relationships, shared citations or nearby passages. Each explains its basis; a connection alone does not establish applicability to your situation.

Federal law — U.S. Code and appendices · legal_authorities

22 U.S.C. § 7653 — Report on treatment activities by relevant executive branch agencies

**(a) In general** Not later than 15 months after May 27, 2003, the President shall submit to appropriate congressional committees a report on the programs and activities of the relevant executive branch agencies that are directed to the treatment of individuals in foreign countries infected with HIV or living with AIDS. **(b) Report elements** The report shall include— (1) a description of the activities of relevant executive branch agencies with respect to— (A) the treatment of opportunistic infections; (B) the use of antiretrovirals; (C) the status of research into successful treatment protocols for individuals in the developing world; (D) technical assistance and training of local health care workers (in countries affected by the pandemic) to administer antiretrovirals, manage side effects, and monitor patients’ viral loads and immune status; (E) the status of strategies to promote sustainability of HIV/AIDS pharmaceuticals (including antiretrovirals) and the effects of drug resistance on HIV/AIDS patients; and (F) the status of appropriate law enforcement officials working to ensure that HIV/AIDS pharmaceutical treatment is not diminished through illegal counterfeiting and black market sales of such pharmaceuticals; (2) information on existing pilot projects, including a discussion of why a given population was selected, the number of people treated, the cost of treatment, the mechanisms established to ensure that treatment is being administered effectively and safely, and plans for scaling up pilot projects (including projected timelines and required resources); and (3) an explanation of how those activities relate to efforts to prevent the transmission of the HIV infection.

Source: Supplied U.S. Code snapshot — release unconfirmed · 22 U.S.C. § 7653

Stored review status: release_metadata_unconfirmed. Same stored citation; legal effect and authority still require review.